Cuál es el precio por HVIVO plc (HVO)

Precio por HVIVO plc (HVO) es de$0.0884456

Cuál es la capitalización de mercado por HVIVO plc (HVO)

Capitalización de mercado por HVIVO plc (HVO) es $608.86K

HVIVO plc (HVO) Desdoblamientos de Acciones

hVIVO plc (HVO) operates as a premier full-service Contract Research Organisation (CRO) focused on early-phase clinical development, globally recognized as the leader in human challenge trials. The company provides a complete spectrum of clinical development services to a wide-ranging and growing client base, which includes seven of the world's ten largest biopharmaceutical companies. A key specialisation for hVIVO is orchestrating human challenge trials across numerous infectious and respiratory diseases, utilising its advanced, London-based quarantine facility, the largest of its kind globally. Additionally, the company offers extensive virology and immunology laboratory services through its hLAB division. Through its German subsidiary, CRS, hVIVO manages a 120-bed capacity across sites in Mannheim and Kiel, delivering early-phase clinical trial expertise, including first-in-human and proof-of-concept studies. Its other subsidiary, Venn Life Sciences, contributes to the biopharma sector by providing specialist early drug development consulting and biometry services. The Group collectively offers integrated drug development solutions, covering stages from preclinical research up to Phase II trials, supported by patient recruitment via FluCamp. Moreover, its five clinical sites facilitate outpatient Phase II and III trials, ensuring a streamlined and effective transition from drug discovery to late-stage development.

Año	Desdoblamiento	Multiplicador	Multiplicador acumulado
Not enough data for the provided dates.

Año

Desdoblamiento

Multiplicador

Multiplicador acumulado

Not enough data for the provided dates.

Empresa	Número de desdoblamientos de acciones	Multiplicador acumulado	País
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Empresa

Número de desdoblamientos de acciones

Multiplicador acumulado

País